🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research study is to see whether receiving a bisphospho...
Status
Recruiting
Location
Wake Forest School of Medicine
Start Date
2023-03-28
Trial ID
NCT04922333
Treatments Being Tested
This is an experimental study, prospective, comparative. This clinical tria...
Status
Terminated
Location
CHU Limoges
Start Date
2016-05
Trial ID
NCT02744482
Treatments Being Tested
Men treated with neoadjuvant luteinizing hormone-releasing hormone (LHRH)-a...
Status
Completed
Location
University of Connecticut Health Center
Start Date
2003-01
Trial ID
NCT00859027
Treatments Being Tested
The present phase II/III, multicenter, randomized, double-blind, parallel g...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02063854
Treatments Being Tested
This study will evaluate whether teriparatide is superior to the active com...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2009-04
Trial ID
NCT00887354
Treatments Being Tested
The purpose of this trial is to compare the difference in bone microarchite...
Status
Terminated
Location
Research Facility
Start Date
2008-07
Trial ID
NCT00577395
Treatments Being Tested
RATIONALE: Preventing bone loss in patients who are receiving chemotherapy ...
Status
Completed
Location
Mobile Infirmary Medical Center
Start Date
2003-03
Trial ID
NCT00054418
Treatments Being Tested
The primary objective of this core study was to show non-inferiority of zol...
Status
Completed
Location
Novartis Investigative site
Start Date
2002-04
Trial ID
NCT00103740
The primary objective of this study is to compare risedronate 35 mg and pla...
Status
Completed
Location
Sanofi-Aventis
Start Date
2006-03
Trial ID
NCT00345644
Treatments Being Tested